Over-expression of β-1,4-galactosyltransferase I, II, and V in human astrocytoma

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 8, 2001, Pages 502-506

  Xu, Songli ^a   Zhu, Xiaoyu ^a   Zhang, Songwen ^a   Yin, Shijie ^b   Zhou, Liangfu ^b   Chen, Chun ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

1,4 galactosyl transferase; Astrocytoma; N glycan; RCA 1

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE I; BETA 1,4 GALACTOSYLTRANSFERASE II; BETA 1,4 GALACTOSYLTRANSFERASE V; GALACTOSYLTRANSFERASE; GLYCOCONJUGATE; PHYTOHEMAGGLUTININ; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ASTROCYTOMA; BRAIN NEOPLASMS; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 0034926049     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320100246     Document Type: Article

References (26)

1. A family of human beta-1,4-galactosyltranferase. Cloning and expression of two novel UDP-galactose: Beta-N-acetylglycosamine beta-1,4-galactosyltransferase, beta 4 Gal-T2 and beta 4 Gal-T3
2. Cloning and expression of a proteoglycan UDP-galactose: β-xylose βb-1,4-galactosyltransferase I
3. Growth retardation and early death of β-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells
4. Apparent reversion of stable in vivo genetic markers detected in tumor cells from spontaneous metastases
5. Surface sialic acid reduces attachment of metastatic tumor cells to collagen type I and fibronectin
6. Growth in inhibitor of human melanoma xenografts in athymic nude mice by swaisonine
7. Beta-1,6-branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia
8. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigen
9. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
10. ARF, PTEN tumor suppressor genes in human glioma cell lines
11. Microheterogeneity and oligosaccharide chains on the β-chains of HLA-DR, human major histocompatibility complex class II antigen, analysed by the lectin-nitrocellulose sheet method
12. Protein measurement with the Folin phenol reagent
13. 2/MTS1 in human cancers
14. Purification, cDNA cloning, and UDP-Gal: Glucosylcermide β-1,4-galactosyltransferase from rat brain
15. Molecular cloning of a human cDNA encoding β-1,4-galactosyltransferase with 37% identity to mammalian UDP-Gal: GlcNAc β-1,4-galactosyltransferase
16. Correlated gene expression between β-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines
17. Cloning of novel member of the UDP-galactose: β-N-acetylglucosamine β-1,4-galactosyltransferase family, β4Gal-T4, involved in glycosphingolipid biosynthesis
18. Involvement of β-1,4-galactosyltransferase V in malignant transformation-associated changes in glycosylation
19. Biological roles of oligosaccharides: All theories are correct
20. α2,3-sialy-transferase mRNA and α2,3-linked glycoprotein are increased in malignant glioma
21. Immunohistochemical localization of β-1,4-galactosyltransferase in human pancreatic tissue
22. β-1,6-N-acetylglycosamine bearing N-glycans in human gliomas: Implications for a role in regulating invasivity
23. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis
24. Down-regulation of β-1,4-galactosyltransferase gene expression by cell-cycle suppressor gene p16
25. Expression of β-1,4-galactosyltransferase in the development mouse brain